Ac2-26 TFA
Ac2-26 TFA, an active N-terminal peptide of annexin A1 (AnxA1), attenuates ischemia-reperfusion-induced acute lung injury. Ac2-26 also decreases AnxA1 protein expression, inhibits the activation of NF-κB and MAPK pathways in the injured lung tissue.
Online Inquiry
| CAT# | R1145 |
| M.F/Formula | C₁₄₃H₂₁₁F₃N₃₂O₄₆S |
| M.W/Mr. | 3203.45 |
| Sequence | One Letter Code: Ala-Met-Val-Ser-Glu-Phe-Leu-Lys-Gln-Ala-Trp-Phe-Ile-Glu-Asn-Glu-Glu-Gln-Glu-Tyr-Val-Gln-Thr-Val-Lys
three Letter Code: AMVSEFLKQAWFIENEEQEYVQTVK |
Write a review
Ask a question
My Review for Ac2-26 TFA
Required fields are marked with *
×
Ask a Question for Ac2-26 TFA
Required fields are marked with *
×
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
